## SHW: The Sherwin-Williams Company - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 3.3% below STRENGTH zone (4.0-10.0%); PEG 3.13 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($327.44)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Assessing Sherwin-Williams (SHW) Valuation As Pricing Power And Cost Discipline Meet Key Earnings Test**
- Source: Simply Wall Street | 20260105T191842 | Neutral | Relevance: 100%
- Analysts are keenly observing Sherwin-Williams' (SHW) upcoming earnings release to validate its pricing power, brand strength, and cost discipline. While the stock has seen a 42.72% return over three years, its one-year return is slightly negative, suggesting a cooling momentum. The company is considered 15% undervalued by some narratives, but its P/E ratio of 31.4x is higher than the industry average, implying a premium that could be vulnerable if sentiment shifts or demand weakens.

**2. The Sherwin-Williams Company $SHW Shares Sold by GoalVest Advisory LLC**
- Source: MarketBeat | 20260105T230829 | Somewhat-Bullish | Relevance: 100%
- GoalVest Advisory LLC significantly reduced its stake in The Sherwin-Williams Company (NYSE:SHW) by 91.1% in Q3, selling 3,065 shares and retaining 300 shares worth $104,000. Sherwin-Williams exceeded Q3 earnings expectations with an EPS of $3.59 and revenue of $6.36 billion, and has provided strong FY2025 guidance. Analysts maintain a "Moderate Buy" rating with an average price target near $390.07, and the company offers a quarterly dividend of $0.79 per share.

**3. Sherwin-Williams to Announce Fourth Quarter and Full Year 2025 Financial Results on January 29, 2026**
- Source: Yahoo Finance | 20260105T130845 | Neutral | Relevance: 100%
- The Sherwin-Williams Company (NYSE: SHW) will release its financial results for the fourth quarter and full year ended December 31, 2025, before market open on Thursday, January 29, 2026. Following this, the company will host a conference call at 10:00 a.m. EST on the same day to discuss these results and provide an outlook for the first quarter and full year 2026. Heidi Petz, Chair, President, and CEO, along with other senior executives, will participate in the webcast.

**4. PPG Industries Inc. stock underperforms Thursday when compared to competitors**
- Source: MSN | 20260105T110858 | Somewhat-Bullish | Relevance: 74%
- PPG Industries Inc. (PPG) stock underperformed on Thursday compared to its competitors, with its shares falling 0.38% to $127.13. Rival companies like Sherwin-Williams Co. and Axalta Coating Systems Ltd. saw gains of 0.45% and 0.28% respectively, while RPM International Inc. experienced a larger decline.

**5. A Look At Ingevity (NGVT) Valuation After Refinery And Industrial Specialties Sale Completion**
- Source: Simply Wall Street | 20260106T000911 | Neutral | Relevance: 60%
- Ingevity (NGVT) has completed the sale of its North Charleston Crude Tall Oil refinery assets and most of its Performance Chemicals Industrial Specialties line, shifting towards higher-margin specialty materials. The stock has seen strong momentum over the past year, with a 51.70% shareholder return. While analysts suggest the stock is undervalued with an intrinsic discount and a fair value around US$69.50, there are still risks from tariff pressures and competitive pricing.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Citigroup | $390 | $392 | -1% |
| 2025-12-18 | Mizuho | $390 | $400 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Citigroup | up | Buy |
| 2025-12-18 | Mizuho | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($0.10M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+1.4%)
- Blackrock Inc.: 7.1% (-0.7%)
- State Street Corpora: 6.2% (-0.9%)
- Price (T.Rowe) Assoc: 3.6% (-1.7%)
- Morgan Stanley: 2.9% (+1.8%)

### Key Risks

1. Valuation stretched: PEG 3.1x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +3.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.13 signals overvaluation risk, limited margin of safety. Forward P/E 27.3x stretched relative to 10% growth. Quality metrics strong (ROE 60%). Balance sheet: $1.1B free cash flow. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $84.8B |
| Beta | 1.26 |
| 52W Range | $308.84 - $379.65 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.13 |
| Forward P/E | 27.3 |
| Current P/E | 29.9 |
| YoY Growth | 9.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.7% to 3.3% (+3.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >4.0% for momentum thesis). MRS_5 at 2.3% confirms short-term momentum alignment. AM_20 at 4.1% shows strong absolute momentum above own 20MA. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram positive (1.66), confirming momentum. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.27% (CS: 71) | Neutral |
| RSI_14 | 63.7 | Neutral |
| MACD Histogram | 1.66 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 0.988x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $340.26
- **Stop Loss:** $327.44 (3.8% risk)
- **Target:** $353.08 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 102
- **Position Value:** $34,706.52
- **Portfolio %:** 34.71%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-03 (Est: $2.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.44 | $3.59 | +4.4% |
| 2025Q2 | $3.81 | $3.38 | -11.2% |
| 2025Q1 | $2.16 | $2.25 | +4.1% |
| 2024Q4 | $2.06 | $2.09 | +1.6% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*